Engineering Fc antibody regions to confer effector function

Details for Australian Patent Application No. 2005335714 (hide)

Owner Macrogenics, Inc.

Inventors Stavenhagen, Jeffrey; Koenig, Scott

Agent Fisher Adams Kelly

Pub. Number AU-B-2005335714

PCT Pub. Number WO2007/024249

Priority 60/626,510 10.11.04 US; 60/636,056 13.12.04 US

Filing date 10 November 2005

Wipo publication date 1 March 2007

Acceptance publication date 26 July 2012

International Classifications

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

C07K 16/08 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2007/024249 Priority application(s): WO2007/024249

26 July 2012 Application Accepted

  Published as AU-B-2005335714

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005335722-A partitioning system

2005335708-Ballistic panel and method of making the same